Themis Medicare Ltd

Themis Medicare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Themis Medicare Ltd

₹ 142 -11.10%
21 May - close price
themismedicare.com BSE: 530199 NSE: THEMISMED
About

Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.[1]

Key Points

Business Segments[1]
A) Hospital Business - Critical Care Division, Intensive Care Division, Institution Business, Exports. Hospital Business is a major growth driver. Critical Care and Intensive Care teams contribute to building Hospital Business with new launches and increased hospital/doctor’s coverage.

Website BSE NSE
  • Market Cap ₹ 1,308 Cr.
  • Current Price ₹ 142
  • High / Low ₹ 317 / 115
  • Stock P/E 43.8
  • Book Value ₹ 43.7
  • Dividend Yield 0.35 %
  • ROCE 10.4 %
  • ROE 7.65 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 3.24 times its book value
  • Company has a low return on equity of 11.9% over last 3 years.
  • Dividend payout has been low at 6.22% of profits over last 3 years
  • Company has high debtors of 159 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
79.80 94.44 91.00 88.78 80.10 96.65 104.78 82.51 97.82 122.99 117.01 93.81 71.70
65.39 74.07 69.66 73.51 69.62 74.91 92.37 74.46 88.53 93.81 99.88 87.84 79.40
Operating Profit 14.41 20.37 21.34 15.27 10.48 21.74 12.41 8.05 9.29 29.18 17.13 5.97 -7.70
OPM % 18.06% 21.57% 23.45% 17.20% 13.08% 22.49% 11.84% 9.76% 9.50% 23.73% 14.64% 6.36% -10.74%
4.25 6.45 6.22 7.13 5.32 6.29 6.66 5.94 4.67 6.93 5.56 1.02 1.55
Interest 1.93 2.26 2.37 2.23 2.71 2.49 2.04 2.68 2.16 2.36 2.44 2.79 2.45
Depreciation 2.39 2.46 2.56 2.67 2.80 3.03 3.07 3.10 3.06 2.41 2.45 2.54 2.53
Profit before tax 14.34 22.10 22.63 17.50 10.29 22.51 13.96 8.21 8.74 31.34 17.80 1.66 -11.13
Tax % 30.61% 21.22% 21.43% 23.94% 18.37% 19.19% 18.91% 10.35% 24.14% 21.25% 19.66% 68.67% -13.12%
9.95 17.40 17.78 13.31 8.41 18.19 11.32 7.37 6.64 24.68 14.29 0.52 -9.66
EPS in Rs 1.08 1.89 1.93 1.45 0.91 1.98 1.23 0.80 0.72 2.68 1.55 0.06 -1.05
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
195 202 232 217 210 184 202 231 395 354 382 406
171 184 194 184 184 181 166 181 299 287 330 356
Operating Profit 24 18 38 33 25 2 36 49 96 67 52 49
OPM % 12% 9% 16% 15% 12% 1% 18% 21% 24% 19% 13% 12%
5 13 3 4 6 5 12 13 18 25 24 11
Interest 16 15 12 12 12 12 13 13 9 10 9 10
Depreciation 9 11 12 7 7 8 8 9 9 10 12 10
Profit before tax 4 5 17 18 11 -13 27 41 95 73 53 40
Tax % 32% -20% 11% 9% 1% -15% 8% 14% 23% 22% 19% 25%
3 6 16 16 11 -11 25 36 73 57 44 30
EPS in Rs 0.32 0.73 1.91 1.77 1.23 -1.17 2.70 3.88 7.92 6.18 4.73 3.24
Dividend Payout % 28% 25% 9% 0% 0% 0% 6% 11% 6% 8% 11% 0%
Compounded Sales Growth
10 Years: 7%
5 Years: 15%
3 Years: 1%
TTM: 6%
Compounded Profit Growth
10 Years: 17%
5 Years: 4%
3 Years: -25%
TTM: -29%
Stock Price CAGR
10 Years: 26%
5 Years: 35%
3 Years: 17%
1 Year: -31%
Return on Equity
10 Years: 13%
5 Years: 15%
3 Years: 12%
Last Year: 8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8 8 9 9 9 9 9 9 9 9 9 9
Reserves 48 51 66 143 160 149 174 209 278 330 368 393
148 140 128 82 80 82 100 87 80 92 96 83
79 77 73 54 56 74 67 65 61 82 93 102
Total Liabilities 284 277 275 289 305 314 350 371 428 514 566 588
121 122 117 124 126 123 116 133 144 162 168 172
CWIP 12 4 6 9 2 2 8 2 3 3 3 3
Investments 4 5 6 23 24 27 35 45 56 70 89 95
147 146 146 133 153 162 191 191 225 279 307 318
Total Assets 284 277 275 289 305 314 350 371 428 514 566 588

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
8 19 26 -2 8 11 0 57 34 16 22 35
-7 -6 -7 -4 -0 -4 -5 -16 -16 -24 -16 -12
2 -18 -13 5 -9 -10 7 -26 -18 0 -9 -26
Net Cash Flow 4 -5 5 -0 -1 -3 2 16 1 -8 -3 -3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 74 82 75 81 120 145 186 123 93 149 170 159
Inventory Days 280 246 243 250 253 287 315 272 150 213 188 233
Days Payable 240 237 145 163 156 187 171 143 79 123 126 142
Cash Conversion Cycle 114 91 172 168 216 244 330 251 164 239 232 250
Working Capital Days 81 78 64 74 131 132 176 152 124 176 180 179
ROCE % 10% 9% 15% 13% 10% -1% 15% 18% 30% 20% 14% 10%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
67.18% 67.17% 67.17% 67.16% 67.16% 67.16% 67.16% 67.15% 67.15% 67.15% 67.15% 67.15%
0.00% 0.02% 0.02% 0.06% 0.04% 0.05% 0.01% 0.03% 0.05% 0.10% 0.10% 0.14%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
32.81% 32.80% 32.78% 32.78% 32.80% 32.77% 32.82% 32.81% 32.79% 32.74% 32.75% 32.70%
No. of Shareholders 5,9156,1266,3625,9276,0076,97011,24411,29511,32214,27017,77317,889

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls